Apogee Therapeutics (APGE) Earnings Date & Reports

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

APGE is expected to report earnings to fall 34.74% to -62 cents per share on September 01

Apogee Therapeutics APGE Stock Earnings Reports

Q2'25

Est.

$-0.62

Q1'25

Missed

by $0.37

Q4'24

Missed

by $0.56

Q3'24

Missed

by $0.30

Q2'24

Missed

by $0.08

The last earnings report on May 12 showed earnings per share of -94 cents, missing the estimate of -57 cents. With 134.32K shares outstanding, the current market capitalization sits at 2.20B.

View a ticker or compare two or three

Compare

APGE